期刊
FEBS JOURNAL
卷 290, 期 17, 页码 4163-4186出版社
WILEY
DOI: 10.1111/febs.16558
关键词
ageing; barrier function; immune system; intestine; obesity
Obesity and ageing are associated with an increased risk of chronic diseases, including metabolic abnormalities and chronic inflammation. The intestine plays a crucial role in promoting chronic tissue inflammation, and abnormalities in the intestinal mucosal barrier are linked to various inflammatory conditions. The intestinal immune system and barrier function have significant impacts on the pathogenesis of obesity and age-related diseases.
Obesity and ageing predispose to numerous, yet overlapping chronic diseases. For example, metabolic abnormalities, including insulin resistance (IR) and type 2 diabetes (T2D) are important causes of morbidity and mortality. Low-grade chronic inflammation of tissues, such as the liver, visceral adipose tissue and neurological tissues, is considered a significant contributor to these chronic diseases. Thus, it is becoming increasingly important to understand what drives this inflammation in affected tissues. Recent evidence, especially in the context of obesity, suggests that the intestine plays an important role as the gatekeeper of inflammatory stimuli that ultimately fuels low-grade chronic tissue inflammation. In addition to metabolic diseases, abnormalities in the intestinal mucosal barrier have been linked to a range of other chronic inflammatory conditions, such as neurodegeneration and ageing. The flow of inflammatory stimuli from the gut is in part controlled by local immunological inputs impacting the intestinal barrier. Here, we will review the impact of obesity and ageing on the intestinal immune system and its downstream consequences on gut barrier function, which is strongly implicated in the pathogenesis of obesity and age-related diseases. In particular, we will discuss the effects of age-related intestinal dysfunction on neurodegenerative diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据